Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial.
The Journal of Urology ( IF 5.9 ) Pub Date : 2024-10-23 , DOI: 10.1097/ju.0000000000004291 David Staskin,Janet Owens-Grillo,Elizabeth Thomas,Eric Rovner
中文翻译：
回复：信件：Vibegron 对接受良性前列腺增生药物治疗的男性膀胱过度活动症持续症状的疗效和安全性：3 期 COURAGE 试验的结果。
更新日期：2024-10-23
The Journal of Urology ( IF 5.9 ) Pub Date : 2024-10-23 , DOI: 10.1097/ju.0000000000004291 David Staskin,Janet Owens-Grillo,Elizabeth Thomas,Eric Rovner
中文翻译：
回复：信件：Vibegron 对接受良性前列腺增生药物治疗的男性膀胱过度活动症持续症状的疗效和安全性：3 期 COURAGE 试验的结果。
京公网安备 11010802027423号